SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 168 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,555,000 | +45.1% | 460,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $1,072,000 | -95.4% | 460,000 | -92.8% | 0.00% | -94.1% |
| Q4 2019 | $23,354,000 | -74.3% | 6,416,000 | -41.5% | 0.02% | -76.7% |
| Q3 2019 | $91,044,000 | -5.0% | 10,975,800 | -1.3% | 0.07% | +2.8% |
| Q2 2019 | $95,795,000 | -19.0% | 11,126,000 | +0.6% | 0.07% | -18.4% |
| Q1 2019 | $118,221,000 | +22.5% | 11,059,000 | +0.2% | 0.09% | +11.5% |
| Q4 2018 | $96,545,000 | -48.5% | 11,033,730 | -1.1% | 0.08% | -38.6% |
| Q3 2018 | $187,488,000 | -11.7% | 11,160,000 | +10.2% | 0.13% | -19.1% |
| Q2 2018 | $212,241,000 | +77.8% | 10,126,000 | +36.5% | 0.16% | +74.4% |
| Q1 2018 | $119,388,000 | +38.0% | 7,420,000 | +62.5% | 0.09% | +36.4% |
| Q4 2017 | $86,526,000 | +53.5% | 4,566,000 | +14.0% | 0.07% | +40.4% |
| Q3 2017 | $56,364,000 | – | 4,006,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 787,973 | $615,000 | 0.77% |
| CM Management, LLC | 600,000 | $468,000 | 0.50% |
| ARMISTICE CAPITAL, LLC | 17,100,000 | $13,338,000 | 0.23% |
| Sargent Investment Group, LLC | 614,600 | $479,000 | 0.15% |
| Ergoteles LLC | 744,275 | $581,000 | 0.02% |
| Sonora Investment Management Group, LLC | 103,000 | $80,000 | 0.01% |
| CAXTON ASSOCIATES LP | 107,135 | $84,000 | 0.01% |
| MCDONALD PARTNERS LLC | 42,570 | $33,000 | 0.01% |
| Pinz Capital Management, LP | 15,600 | $12,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 8,051,858 | $6,281,000 | 0.01% |